Medicinova Inc financial data

Symbol
MNOV on Nasdaq
Industry
Pharmaceutical Preparations
Location
4275 Executive Square, Suite 300, La Jolla, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.78K % +6.52%
Debt-to-equity 5.49 % -5.99%
Return On Equity -13.4 % +25.8%
Return On Assets -12.7 % +25.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49M shares 0%
Common Stock, Shares, Outstanding 49M shares 0%
Entity Public Float 109M USD -6.9%
Common Stock, Value, Issued 49K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 49M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1M USD
Research and Development Expense 5.5M USD -23.6%
General and Administrative Expense 4.95M USD -13.4%
Operating Income (Loss) -9.82M USD +26.7%
Net Income (Loss) Attributable to Parent -8.16M USD +34.4%
Earnings Per Share, Basic -0.16 USD/shares +38.5%
Earnings Per Share, Diluted -0.16 USD/shares +38.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44.3M USD -16.1%
Accounts Receivable, after Allowance for Credit Loss, Current 1M USD
Assets, Current 45.5M USD -15%
Property, Plant and Equipment, Net 35.8K USD -34.4%
Operating Lease, Right-of-Use Asset 443K USD -33.8%
Goodwill 9.6M USD 0%
Other Assets, Noncurrent 19K USD -73.9%
Assets 60.4M USD -12.1%
Accounts Payable, Current 668K USD +21.8%
Employee-related Liabilities, Current 824K USD -10.4%
Liabilities, Current 2.49M USD -11.6%
Deferred Income Tax Liabilities, Net 202K USD 0%
Operating Lease, Liability, Noncurrent 302K USD -41.8%
Other Liabilities, Noncurrent 302K USD -41.8%
Liabilities 3M USD -15.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -132K USD -8.66%
Retained Earnings (Accumulated Deficit) -421M USD -1.98%
Stockholders' Equity Attributable to Parent 57.4M USD -11.9%
Liabilities and Equity 60.4M USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.87M USD -21.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.86M USD -111%
Deferred Tax Assets, Valuation Allowance 83.4M USD +1.22%
Deferred Tax Assets, Gross 84.7M USD +1.19%
Operating Lease, Liability 493K USD -31.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.18M USD +34.3%
Lessee, Operating Lease, Liability, to be Paid 557K USD -34.1%
Property, Plant and Equipment, Gross 489K USD +2.35%
Operating Lease, Liability, Current 190K USD -5.58%
Lessee, Operating Lease, Liability, to be Paid, Year Two 206K USD -9.71%
Lessee, Operating Lease, Liability, to be Paid, Year One 223K USD -15.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 64.5K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.3K USD -91.6%
Deferred Tax Assets, Operating Loss Carryforwards 70M USD -0.23%
Unrecognized Tax Benefits 1.59M USD +77.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.3K USD -91.6%
Operating Lease, Payments 257K USD +0.39%
Depreciation, Depletion and Amortization 5.35K USD +30.3%
Share-based Payment Arrangement, Expense 405K USD -60.2%